Clinuvel Pharmaceuticals Limited has released a press release.
SCENESSE approved for EPP in Canada
Earlier from Clinuvel Pharmaceuticals
- CLINUVEL publicly files 20-F to U.S. SEC
- CLINUVEL update on Level II ADR upgrade, Nasdaq uplist
- FDA relaxes SCENESSE postmarketing requirement
- CLINUVEL receives final EMA scientific advice for pivotal Phase III vitiligo study